Table 1.
Patient Characteristics
| Demographics | Number of patients |
|---|---|
| Number of patients | 159 |
| Age, years | |
| Median | 68 |
| Range | 49 – 87 |
| Race | |
| Caucasians | 131 |
| African-Americans | 28 |
| Gleason score | |
| Median | 7 |
| Range | 3 – 10 |
| Gleason score | |
| ≤ 6 | 53 |
| 7 | 62 |
| 8 – 10 | 42 |
| Indeterminate | 2 |
| On-study PSA, ng/mL | |
| Median | 5.1 |
| Range | 0.9 – 311.8 |
| Prior Therapy | |
| Surgery alone | 31 |
| Radiotherapy alone | 33 |
| Surgery and Hormonal Therapy | 2 |
| Radiotherapy and Hormonal Therapy | 17 |
| Surgery and Radiation Therapy | 59 |
| Surgery, Radiation and Hormonal Therapy | 17 |
| ECOG Performance Status | |
| 0 | 142 |
| 1 | 17 |
| Evaluable patients with baseline T | 129 |
| Baseline T (ng/mL) prior to OPA, median | 311.5 |
| Range | 10 – 1000 |
| Baseline T (ng/mL) prior to OPB, median | 326 |
| Range | 20 – 1400 |